Following a five-day bench trial in the matter in February 2017 and after having considered the entire record in the case and the applicable law, the Court, through Memorandum, entered
Continue Reading Judge Sleet Invalidates Patents-in-Suit After Finding of Obviousness and Enters Judgment in Favor of Alleged Infringer in Hatch-Waxman Action

By Memorandum Opinion entered by The Honorable Sue L. Robinson in Merck Sharp & Dohme Corp. v. Teva Pharmaceuticals USA, Inc., Civil Action No. 14-874-SLR (D.Del., November 16, 2016),
Continue Reading After Two Day Bench Trial in ANDA Action, Judge Robinson Finds The ‘353 Patent Valid But Not Infringed by Generic

By Trial Opinion entered by The Honorable Richard G. Andrews, following a bench trial, in Endo Pharmaceuticals Inc. et al. v. Amneal Pharmaceuticals, LLC et al., Civil Action No.
Continue Reading Judge Andrews Concludes that Defendants Failed to Prove Affirmative Defenses of Obviousness and Implied License in ANDA Action

By Memorandum Opinion entered by The Honorable Gregory M. Sleet in Pfizer Inc. v. Sandoz Inc., et al., Civil Action No. 13-110-GMS (D.Del., Apr. 20, 2016), the Court denied
Continue Reading Judge Sleet Denies Defendants’ Post-Trial Proposed Finding of Invalidity of Patents-in-Suit Due To Obviousness

By Memorandum Order entered by The Honorable Gregory M. Sleet in Merck Sharp & Dohme B.V. v. Warner Chilcott Company, LLC, Civil Action No. 13-2088-GMS (D.Del., February 25, 2016),
Continue Reading Judge Sleet Issues Order Construing Remaining Term in Dispute During Bench Trial of Infringement Action